Top Midday Decliners

MT Newswires Live

Jul 23

Wedbush Securities downgraded Replimune Group (REPL) to neutral from outperform, while adjusting its price target to $4 from $19.

Replimune could need a "significant restructuring" in the near term to accommodate changes to the study of RP1 in combination with nivolumab in advanced melanoma, Wedbush said in a note Tuesday.

Shares of Replimune sank 76% following an increase in intraday trading volume to over 65.6 million from a daily average of about 1.57 million.

ProMIS Neurosciences (PMN) said Tuesday that it signed an agreement with an existing institutional investor to issue and sell about $2.4 million of warrants.

The warrants were sold at $0.1875 a piece through a private investment in public equity financing.

Shares of ProMIS dropped about 26% as more than 13.2 million shares traded intraday, versus a daily average of about 6.5 million.

Lockheed Martin (LMT) stock dropped 8.5% amid heavy trading after the company posted a decline in fiscal Q2 earnings and cut its 2025 earnings guidance.

More than 5.95 million shares traded intraday, compared with a daily average of about 1.43 million.

Price: 2.97, Change: -9.36, Percent Change: -75.90

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2553268349"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553268349\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553268349?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-23 02:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553268349","market":"us","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> Wedbush Securities downgraded Replimune Group (REPL) to neutral from outperform, while adjusting its price target to $4 from $19.</p><p>Replimune could need a \"significant restructuring\" in the near term to accommodate changes to the study of RP1 in combination with nivolumab in advanced melanoma, Wedbush said in a note Tuesday.</p><p>Shares of Replimune sank 76% following an increase in intraday trading volume to over 65.6 million from a daily average of about 1.57 million.</p><p><a href=\"https://laohu8.com/S/PMN\">ProMIS Neurosciences</a> (PMN) said Tuesday that it signed an agreement with an existing institutional investor to issue and sell about $2.4 million of warrants.</p><p>The warrants were sold at $0.1875 a piece through a private investment in public equity financing.</p><p>Shares of ProMIS dropped about 26% as more than 13.2 million shares traded intraday, versus a daily average of about 6.5 million.</p><p><a href=\"https://laohu8.com/S/LMT\">Lockheed Martin</a> (LMT) stock dropped 8.5% amid heavy trading after the company posted a decline in fiscal Q2 earnings and cut its 2025 earnings guidance.</p><p>More than 5.95 million shares traded intraday, compared with a daily average of about 1.43 million.</p><p>Price: 2.97, Change: -9.36, Percent Change: -75.90</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-23 02:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Wedbush Securities downgraded Replimune Group (REPL) to neutral from outperform, while adjusting its price target to $4 from $19.</p><p>Replimune could need a \"significant restructuring\" in the near term to accommodate changes to the study of RP1 in combination with nivolumab in advanced melanoma, Wedbush said in a note Tuesday.</p><p>Shares of Replimune sank 76% following an increase in intraday trading volume to over 65.6 million from a daily average of about 1.57 million.</p><p><a href=\"https://laohu8.com/S/PMN\">ProMIS Neurosciences</a> (PMN) said Tuesday that it signed an agreement with an existing institutional investor to issue and sell about $2.4 million of warrants.</p><p>The warrants were sold at $0.1875 a piece through a private investment in public equity financing.</p><p>Shares of ProMIS dropped about 26% as more than 13.2 million shares traded intraday, versus a daily average of about 6.5 million.</p><p><a href=\"https://laohu8.com/S/LMT\">Lockheed Martin</a> (LMT) stock dropped 8.5% amid heavy trading after the company posted a decline in fiscal Q2 earnings and cut its 2025 earnings guidance.</p><p>More than 5.95 million shares traded intraday, compared with a daily average of about 1.43 million.</p><p>Price: 2.97, Change: -9.36, Percent Change: -75.90</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4604","symbol_name":"机器人概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2553268349","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553268349","pubTimestamp":1753209402,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Wedbush Securities downgraded Replimune Group  to neutral from outperform, while adjusting its price target to $4 from $19.Replimune could need a \"significant restructuring\" in the near term to accommodate changes to the study of RP1 in combination with nivolumab in advanced melanoma, Wedbush said in a note Tuesday.Shares of Replimune sank 76% following an increase in intraday trading volume to over 65.6 million from a daily average of about 1.57 million.ProMIS Neurosciences  said Tuesday that it signed an agreement with an existing institutional investor to issue and sell about $2.4 million of warrants.The warrants were sold at $0.1875 a piece through a private investment in public equity financing.Shares of ProMIS dropped about 26% as more than 13.2 million shares traded intraday, versus a daily average of about 6.5 million.Lockheed Martin  stock dropped 8.5% amid heavy trading after the company posted a decline in fiscal Q2 earnings and cut its 2025 earnings guidance.More than 5.95 ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4604":"机器人概念","LU1929549753.HKD":"FRANKLIN INCOME \"A\" (HKD) INC","BK4564":"太空概念","BK4139":"生物科技","REPL":"Replimune Group Inc.","BK4187":"航天航空与国防","PMN":"ProMIS Neurosciences Inc","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","BK4588":"碎股","BK4516":"特朗普概念","BK4585":"ETF&股票定投概念"},"translate_title":"午盘跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PMN":0.9,"REPL":0.9},"content_text":"Wedbush Securities downgraded Replimune Group (REPL) to neutral from outperform, while adjusting its price target to $4 from $19.Replimune could need a \"significant restructuring\" in the near term to accommodate changes to the study of RP1 in combination with nivolumab in advanced melanoma, Wedbush said in a note Tuesday.Shares of Replimune sank 76% following an increase in intraday trading volume to over 65.6 million from a daily average of about 1.57 million.ProMIS Neurosciences (PMN) said Tuesday that it signed an agreement with an existing institutional investor to issue and sell about $2.4 million of warrants.The warrants were sold at $0.1875 a piece through a private investment in public equity financing.Shares of ProMIS dropped about 26% as more than 13.2 million shares traded intraday, versus a daily average of about 6.5 million.Lockheed Martin (LMT) stock dropped 8.5% amid heavy trading after the company posted a decline in fiscal Q2 earnings and cut its 2025 earnings guidance.More than 5.95 million shares traded intraday, compared with a daily average of about 1.43 million.Price: 2.97, Change: -9.36, Percent Change: -75.90","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}